1085686
Apozeal Pharmaceuticals Inc. — FEI 3004536846
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 9, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Levittown, PA (United States)
Citations
| ID | CFR | Description |
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 1177 | 21 CFR 211.63 | Equipment Design, Size and Location |
| 1220 | 21 CFR 211.67(b)(3) | Cleaning SOPs/instructions |
| 1450 | 21 CFR 211.113(a) | Procedures for non-sterile drug products |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |
| 2028 | 21 CFR 211.192 | Extent of discrepancy, failure investigations |
| 21295 | 21 CFR 211.110(b) | In-process conformity - examination, sample testing |
| 3611 | 21 CFR 211.160(b)(3) | Acceptance of drug products |